-- Paper, Packaging & Forest Products Brief: RBC Believes Canada Producers Are "Largely Operating Meaningfully Below Breakeven Levels"-March 2024-www.financetom.com

-- Paper, Packaging & Forest Products Brief: RBC Believes Canada Producers Are "Largely Operating Meaningfully Below Breakeven Levels"

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

-- Paper, Packaging & Forest Products Brief: RBC Believes Canada Producers Are "Largely Operating Meaningfully Below Breakeven Levels"

Sep 29, 2025 8:10 AM

10:29 AM EDT, 09/29/2025 (MT Newswires) --

Price: 9.53, Change: -0.03, Percent Change: -0.31

Previous page： American Hotel Income Properties REIT 3.2% Higher as Announces Stock Buyback Next page： Psyence Biomedical Regains Nasdaq Compliance for Continued Listing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

American Hotel Income Properties REIT 3.2% Higher as Announces Stock Buyback

Dec 23, 2024

11:16 AM EST, 12/23/2024 (MT Newswires) -- American Hotel Income Properties REIT (HOT-UN.TO, HOT-U.TO) up 3.2% on last look, on Monday said the Toronto Stock Exchange has accepted its notice to buy back up to 7.5 million units. The buyback period will run from Dec. 30 for one year. The company's units were last seen up $0.015, to $0.475, on...

Psyence Biomedical Regains Nasdaq Compliance for Continued Listing

Dec 23, 2024

11:17 AM EST, 12/23/2024 (MT Newswires) -- Psyence Biomedical ( PBM ) said Monday it received a Nasdaq notification that the firm has regained compliance with all applicable Nasdaq listing requirements, including minimum market value and stockholders' equity requirement. With Nasdaq compliance, a debt free balance sheet and a cash position of $5.6 million, the company is well positioned to...

Cosciens Biopharma Down 3.3% As Repositions as Life Sciences Business

Dec 23, 2024

11:16 AM EST, 12/23/2024 (MT Newswires) -- Cosciens Biopharma ( CSCI ) was at last look was down 3.3% Monday after saying that it is repositioning itself as a life sciences business offering natural based products. This follows last August's conclusion of a Phase 3 study evaluating macimorelin for the diagnosis of Childhood Onset Growth Hormone Deficiency (CGHD) that had...

Dec 23, 2024

...